Stona For Children Syrup
NDC Package 49873-108-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Stona For Children (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide) syrups is usesFor the temporary relief of the following cold symptoms  minor aches and painsheadachesneezingrunny nosecough due to minor throat and bronchial irritationtemporarily reduces fever. This formulation utilizes a syrup delivery system. Marketed by Sato Pharmaceutical Co., Ltd., this product is identified by NDC 49873-108 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
49873-108-01
Package Description
1 BOTTLE in 1 CARTON / 120 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
49873010801
RxNorm Crosswalk
  • RxCUI: 1236070 - acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG in 15 mL Oral Solution
  • RxCUI: 1236070 - acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution
  • RxCUI: 1236070 - APAP 21.7 MG/ML / Chlorpheniramine Maleate 0.13 MG/ML / Dextromethorphan Hydrobromide 0.67 MG/ML Oral Solution
  • RxCUI: 1236070 - APAP 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG per 15 ML Oral Solution

Clinical Specifications

Proprietary Name
Stona For Children
Non-Proprietary Name
Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide
Substance Name
Acetaminophen; Chlorpheniramine Maleate; Dextromethorphan Hydrobromide
Dosage Form
Syrup - An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
UsesFor the temporary relief of the following cold symptoms  minor aches and painsheadachesneezingrunny nosecough due to minor throat and bronchial irritationtemporarily reduces fever

Regulatory & Marketing

Labeler Name
Sato Pharmaceutical Co., Ltd.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-03-2001
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49873-108-01 identifies a specific commercial package of 1 bottle in 1 carton / 120 ml in 1 bottle of Stona For Children, a human over the counter drug labeled by Sato Pharmaceutical Co., Ltd.. This syrup is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sato Pharmaceutical Co., Ltd. on January 03, 2001. The current certification is valid through December 31, 2026.

How is this Sato Pharmaceutical Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49873010801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49873-108-01
11-Digit CMS (5-4-2)
49873-0108-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.